SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-302686
Filing Date
2020-11-24
Accepted
2020-11-24 17:01:01
Documents
13
Period of Report
2020-11-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d35278d8k.htm   iXBRL 8-K 29239
2 EX-10.1 d35278dex101.htm EX-10.1 36521
  Complete submission text file 0001193125-20-302686.txt   199556

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA qtnt-20201120.xsd EX-101.SCH 2731
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE qtnt-20201120_lab.xml EX-101.LAB 18041
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qtnt-20201120_pre.xml EX-101.PRE 11261
6 EXTRACTED XBRL INSTANCE DOCUMENT d35278d8k_htm.xml XML 3594
Mailing Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA
Business Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA 41274832286
Quotient Ltd (Filer) CIK: 0001596946 (see all company filings)

IRS No.: 264719797 | State of Incorp.: Y9 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-36415 | Film No.: 201344973
SIC: 2835 In Vitro & In Vivo Diagnostic Substances